ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 43 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,282,000 | – | 124,843 | – | 0.69% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SEVEN EIGHT CAPITAL, LP | 46,819 | $2,031,000 | 0.47% |
Orbimed Advisors | 1,206,886 | $49,844,000 | 0.47% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 25,000 | $1,033,000 | 0.40% |
ARK Investment Management | 3,331,889 | $137,607,000 | 0.27% |
FEDERATED HERMES, INC. | 3,203,000 | $132,284,000 | 0.26% |
MGO ONE SEVEN LLC | 26,990 | $1,114,000 | 0.19% |
Koss-Olinger Consulting, LLC | 20,000 | $826,000 | 0.14% |
Jump Financial, LLC | 35,400 | $1,462,000 | 0.14% |
Graham Capital Management, L.P. | 74,262 | $3,067,000 | 0.14% |
New England Research & Management, Inc. | 6,005 | $248,000 | 0.14% |